Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amarin's Anchor Gamble Sends Stock Up 20% On 'No News' News
Seeking Alpha
Friday, December 20, 2013 - 11:52am
tags:
Amarin, Vascepa, FDA
Merck Announces Launch of a New Business Focused on Comprehensive, Evidence-Based Weight Management Interventions in the U.S.
Marketwatch
Friday, December 20, 2013 - 11:50am
tags:
obesity, weight loss, Merck
Inovio CEO Interview: PD1/PDL1 Inhibitors, Immunotherapy And Why Investors Should Be Excited About 2014
Seeking Alpha
Friday, December 20, 2013 - 11:49am
tags:
Inovio, Pharma CEOs, PDL-1, immunotherapy, Joseph Kim, Bristol-Myers Squibb, Roche, Dendreon, GSK, ImmunoCellular Therapeutics, Merck, Northwest Biotherapeutics
Intrexon to Acquire Medistem to Generate Multipotent Cells
Yahoo
Friday, December 20, 2013 - 11:45am
tags:
Intrexon, MediStem, M&A
Ariad says FDA OKs marketing of Iclusig after adding new safety warnings
Yahoo/AP
Friday, December 20, 2013 - 11:35am
tags:
Ariad Pharmaceuticals, FDA, Iclusig, warnings
Amarin Says U.S. Ruling on Fish Oil Pill Delayed on Trial
Bloomberg
Friday, December 20, 2013 - 8:49am
tags:
Vascepa, FDA, Amarin
Hanmi does not infringe AstraZeneca's Nexium -U.S. appeals court
Reuters
Friday, December 20, 2013 - 8:47am
tags:
patents, Hanmi Pharma, Nexium, AstraZeneca
Antares Pharma announces notice of allowance for new patent
The Fly on the Wall
Friday, December 20, 2013 - 8:45am
tags:
patents, devices, Antares Pharma, injectables
Novogen Announces Establishment of Global Collaboration to Drive The Development of Drugs to Treat Brain Cancer
Yahoo
Friday, December 20, 2013 - 8:43am
tags:
Novogen, R&D, Trilexium, glioblastoma multiforme
Novartis recalls millions of sample drugs over contamination worries
Marketwatch
Friday, December 20, 2013 - 8:42am
tags:
Novartis, samples, recalls
EU backs J&J's TB drug, postpones decision on Teva MS pill
Yahoo/Reuters
Friday, December 20, 2013 - 8:39am
tags:
Europe, Teva, MS, multiple sclerosis, laquinimod, Sirturo
Immunocellular Shares Are Set For A Rebound
Seeking Alpha
Friday, December 20, 2013 - 8:37am
tags:
ImmunoCellular Therapeutics, ICT-107, Northwest Biotherapeutics
BioCryst Files Peramivir NDA for the Treatment of Influenza
Yahoo
Friday, December 20, 2013 - 8:35am
tags:
Biocryst, peramivir, Flu
Biotech Stocks: A Year in Review
Yahoo/TheStreet.com
Friday, December 20, 2013 - 8:34am
tags:
Amgen, Teva, Forest Labs, AstraZeneca, Medivation, JNJ
Jazz to Buy Gentium for $1 Billion for Rare-Disease Drugs
Bloomberg
Thursday, December 19, 2013 - 6:07pm
tags:
Jazz Pharmaceuticals, M&A, Gentium
Markets That Can Propel Merck
Forbes
Thursday, December 19, 2013 - 5:12pm
tags:
Merck, Gardasil, lambrolizumab, Janumet, Januvia
NeoStem: Continued Progress And 2014 Catalysts
Seeking Alpha
Thursday, December 19, 2013 - 5:08pm
tags:
NeoStem, AMI-001
Vertex Cystic Fibrosis Trial Has Good, Bad News
Investors.com
Thursday, December 19, 2013 - 11:50am
tags:
Vertex, cystic fibrosis, Kalydeco
Can Gilead's $1,000 Pill Eradicate Hepatitis C?
Forbes
Thursday, December 19, 2013 - 11:35am
tags:
Gilead, hepatitis C, Sovaldi, ledipasvir
The Future Is Bright: Keryx Biopharmaceuticals Receives Patent Protection
Wall St Cheat Sheet
Thursday, December 19, 2013 - 11:34am
tags:
Keryx, patents, Zerenex

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.